GW Pharmaceuticals Plc GWPHV

$GWPH: Why Investors Should be Bullish About GWPH

[Isodog2018]

"We believe GW Pharmaceuticals is a possible buying opportunity for two reasons. The first reason is that GW Pharmaceuticals is poised to start selling in Europe in 2020 as the European Commission approved GW Pharmaceuticals Epidiolex as a treatment for seizures in two rare and severe forms of epilepsy. This should add to their revenue as they push towards profitability. Once the company can achieve profitability in a sector where investors’ patience is growing thin, it should make the company stand out in the crowd and solidify their business model. This could in itself restore investor confidence despite their growth concerns."

https://stocknews.com/news/gwph-why-investors-should-be-bullish-gw-pharmaceuticals-gwph/

Europe 2020